logo
AI Icon𝛼SK or Search
ENTITY

TuHURA Biosciences (HURA US)

11
Analysis
Health Care • United States
TuHURA Biosciences, Inc. is a phase 3 registration-stage immuno-oncology company. The Company focuses on developing technologies to overcome resistance to cancer immunotherapy. TuHURA Biosciences operates in the United States.
more
Exchange Announcement • 25 Sep 2026 05:00

Current Report (Form 8-K | Period ending 2026-09-21)

Exchange Announcement • 17 Sep 2026 21:00

Current Report (Amendment) (Form 8-K/A | Period ending 2026-09-10)

Exchange Announcement • 17 Sep 2026 05:00

Current Report (Form 8-K | Period ending 2026-09-10)

Exchange Announcement • 05 Sep 2026 05:00

Current Report (Form 8-K | Period ending 2026-09-02)

Exchange Announcement • 22 Aug 2026 05:00

Current Report (Form 8-K | Period ending 2026-08-20)

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x